The Evidence Behind the Hype.
A physician-reviewed, evidence-based examination of BPC-157 from the Founder’s Institute of Medicine & Education.
This digital monograph separates what has been demonstrated in humans, what has been observed in preclinical research, what remains theoretical, and what simply is not yet known.
BPC-157 is widely discussed. But what does the evidence actually show?
The BPC-157 Peptide Intelligence Monograph from the Founder’s Institute of Medicine & Education is an independent educational review of the scientific evidence surrounding one of today’s most discussed investigational peptides.
Rather than beginning with a conclusion, we begin with the evidence.
Using the Founder’s Institute Peptide Evidence Standard (FIPES), claims are evaluated individually and the strength, maturity, safety knowledge, and human relevance of the supporting evidence are made transparent.
Inside the monograph:
• BPC-157 identity and scientific background
• Proposed mechanisms of action
• Human clinical evidence
• Preclinical research and translational limitations
• Gastrointestinal research
• Musculoskeletal and tissue-repair research
• Angiogenesis and vascular considerations
• Safety and toxicology
• Regulatory and compounding considerations
• Competitive-athlete / anti-doping considerations
• Claim-specific FIPES Evidence Cards
• What We Know / What We Don’t Know
• Claims vs. Evidence
• Research gaps and unanswered questions
• Physician Review & Publication Record
• Source documentation and references
Peptide research is developing rapidly, while public claims frequently move faster than clinical evidence.
The Founder’s Institute created Peptide Intelligence to provide readers with something different: an independent assessment that clearly distinguishes biological plausibility, preclinical findings, preliminary human observations, and demonstrated clinical evidence.
We do not grade a peptide as “good” or “bad.”
We grade the evidence supporting specific claims.
WE GRADE THE EVIDENCE WE FIND — NOT THE CONCLUSION WE HOPED TO FIND.
Evidence Before Hype.
Transparency Before Certainty.
Integrity Before Revenue.
Digital publication — PDF
Designed for healthcare professionals, researchers, educators, students, and informed readers seeking a rigorous understanding of the evidence surrounding BPC-157.
EDUCATIONAL USE ONLY
This publication is provided for educational and informational purposes only. It does not constitute medical advice, diagnosis, treatment recommendations, or individualized clinical guidance.
BPC-157 is not an FDA-approved drug. Discussion of experimental or investigational substances within this publication does not constitute endorsement or recommendation of their use.
Readers should consult an appropriately qualified healthcare professional regarding individual medical decisions.
This publication is provided solely for educational and informational purposes. It does not constitute medical advice, diagnosis, prescribing guidance, or a recommendation for individual treatment. It is not intended to replace evaluation, consultation, or treatment by a qualified healthcare professional. Treatment decisions must be based on the individual patient's circumstances and made in consultation with an appropriately licesnsed healthcare professional.